Lepu Medical Technology(Beijing) Co., Ltd. released its Q3 report for 2025, showing a total revenue of 4.939 billion yuan for the first three quarters, marking a year-on-year increase of 3.20%. The net profit attributable to shareholders of the listed company stood at 982 million yuan, reflecting a year-on-year rise of 22.35%. The net profit after excluding non-recurring gains and losses reached 941 million yuan, up 28.18% year-on-year. The basic earnings per share were 0.5327 yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments